Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Pandolfi

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Leukemia|December 17, 2005
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndromeP Maslak, S Chanel, L H Camacho, et al.
Molecular and Cellular Biochemistry|June 21, 2008
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressorP P Scaglioni, T M Yung, S Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Acute leukemia with promyelocytic features in PML/RARalpha transgenic miceL Z He, C Tribioli, R Rivi, et al.
The Journal of Biological Chemistry|October 5, 2001
PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor RbM M Khan, T Nomura, H Kim, et al.
Leukemia|September 26, 2014
Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML)E Coppin, V Gelsi-Boyer, X Morelli, et al.
Cell Death and Differentiation|January 24, 2015
TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activationM T Epping, A Lunardi, D Nachmani, et al.
Science (New York, N.Y.)|March 21, 1998
Role of PML in cell growth and the retinoic acid pathwayZ G Wang, L Delva, M Gaboli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2001
Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1C Liao, X Y Wang, H Q Wei, et al.
Blood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.
Nature Genetics|December 28, 1999
A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteinsS Zhong, L Delva, C Rachez, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Leukemia|December 17, 2005
Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndromeP Maslak, S Chanel, L H Camacho, et al.
Molecular and Cellular Biochemistry|June 21, 2008
CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressorP P Scaglioni, T M Yung, S Choi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1997
Acute leukemia with promyelocytic features in PML/RARalpha transgenic miceL Z He, C Tribioli, R Rivi, et al.
The Journal of Biological Chemistry|October 5, 2001
PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor RbM M Khan, T Nomura, H Kim, et al.
Leukemia|September 26, 2014
Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML)E Coppin, V Gelsi-Boyer, X Morelli, et al.
Cell Death and Differentiation|January 24, 2015
TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activationM T Epping, A Lunardi, D Nachmani, et al.
Science (New York, N.Y.)|March 21, 1998
Role of PML in cell growth and the retinoic acid pathwayZ G Wang, L Delva, M Gaboli, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2001
Altered myelopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin A1C Liao, X Y Wang, H Q Wei, et al.
Blood|December 15, 1993
Absence of reverse transcription-polymerase chain reaction detectable residual disease in patients with acute promyelocytic leukemia in long-term remissionD Diverio, P P Pandolfi, A Biondi, et al.
Nature Genetics|December 28, 1999
A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteinsS Zhong, L Delva, C Rachez, et al.
Pageof 13